C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors Beam Therapeutics Inc. Transaction History
C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors
- $1.18 Trillion
- Q4 2024
A detailed history of C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors holds 13,287 shares of BEAM stock, worth $344,266. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,287Holding current value
$344,266% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BEAM
# of Institutions
235Shares Held
75.6MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$213 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$198 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$169 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$125 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.82B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...